Featured News
Expanding Intrathecal Dosing Services to Meet Customer Need
The right services at the right time, every step of the way
Charles River is dedicated to delivering timely and reliable service when and where you need it. In response to an increased demand for intrathecal dosing studies and the importance of speed in the drug development process, we have expanded our capabilities at our North American sites and one in Europe.
This expanded network capacity, along with our integrated team of specialized surgeons, allows us to better meet your needs while ensuring the highest quality and best practices across all our facilities.
Our global network of intrathecal dosing services includes eight sites offering clients greater flexibility in booking studies within the shortest delay and closest proximity:
- Ashland, Ohio*
- Laval, Canada*
- Lyon, France*
- Mattawan, Michigan
- Reno, Nevada
- Senneville, Canada
- Sherbrooke, Canada*
- Shrewsbury, Massachusetts*
*Sites with new capabilities
Timely and Flexible Service
When you outsource your program to Charles River, you can expect timely, flexible study starts, and robust data that satisfies regulations. Our continual investment in facilities, technology, and talent means you have access to valuable resources without having to bring them in-house, saving you time and money on the path to market.
Cell & Gene Therapy Services: From Discovery to Commercialization
Learn more about our end-to-end portfolio of cell and gene therapy solutions and connect with our team of scientific and regulatory experts who can help support and guide your program, every step of the way.
Get the details